February 17, 2026 · Form 4 insider transaction
Jallal Bahija bought 395,066 shares of IMMUNOCORE HLDGS PLC at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 2 days after the transaction.
25% of the shares subject to the option award shall vest on February 17, 2027, and 6.25% of the shares subject to the option award shall vest in quarterly installments thereafter, subject to the Reporting Person's continuous service through each such vesting date.; Ordinary Shares may be represented by American Depositary Shares. Each American Depositary Share represents one Ordinary Share.